Streetbeat News

Stock Prices

AQMS

Aqua Metals, Inc. (NASDAQ:AQMS) announced progress on the Sierra ARC buildout and ongoing efforts to finance the remainder of its construction and commissioning. The company is deploying cash preservation initiatives and extending pilot operations to support strategic partner development.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 8:29 pm

KIDS

OrthoPediatrics (NASDAQ:KIDS) reported Q2 2024 adjusted EPS of $(0.23), beating the estimate of $(0.27). Sales were $52.802M, surpassing the $52.495M estimate and marking a 33.48% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 8:28 pm

AIMD

Ainos shares are trading lower after the company reported a year-over-year decrease in Q2 revenue results.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 8:28 pm

VNO

Vornado Realty (NYSE:VNO) reported Q2 2024 earnings per share (EPS) of $0.57, beating the analyst estimate of $0.54. Sales were $450.266 million, also surpassing the estimate of $439.277 million. However, both EPS and sales were down compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 8:27 pm

MTRN

Materion (NYSE:MTRN) reported Q2 2024 adjusted EPS of $1.42, beating the estimate of $1.39. Sales were $425.866M, surpassing the $424.020M estimate. EPS increased by 2.9% YoY, and sales grew by 6.85% YoY.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 8:27 pm

MED

Medifast (NYSE:MED) reported Q2 2024 adjusted EPS of $0.92, significantly beating the analyst estimate of $0.39. However, sales of $168.558 million missed the $174.050 million estimate and were down 43.09% year-over-year.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 8:27 pm

HIMS

Hims & Hers Health, Inc. (NYSE:HIMS) reported better-than-expected Q2 results with earnings of 6 cents per share and sales of $315.648 million, both beating analyst estimates. The company saw a 51.82% increase in sales year-over-year and a significant rise in free cash flow. Despite the positive results, HIMS shares fell 10.59% after-hours.

Portfolio Pulse from Erica Kollmann

August 05, 2024 | 8:26 pm

RXST

RxSight (NASDAQ:RXST) reported Q2 sales of $34.887 million, surpassing the analyst consensus estimate of $32.283 million by 8.07%. This marks a 67.65% increase over the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 8:26 pm

XPER

Xperi (NYSE:XPER) reported Q2 2024 adjusted EPS of $0.12, significantly beating the analyst estimate of $(0.03). However, the company's sales of $119.591 million missed the $121.653 million estimate and were down 5.76% year-over-year.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 8:25 pm

MWA

MUELLER WATER PRODUCTS shares are trading higher after the company reported better-than-expected Q3 financial results and issued FY24 guidance.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 8:25 pm